Allurion Technologies, Inc. ("Allurion" or the "Company") (NYSE: ALUR), a company dedicated to ending obesity, today announced its intention to initiate a clinical study on the combination of the ...

The study will focus on combination use of the Allurion Balloon with lower dose GLP-1s with the goal of demonstrating improved long-term tolerability and adherence to GLP-1 therapy. Previous ...

Allurion Technologies (ALUR) announced its intention to initiate a clinical study on the combination of the Allurion Balloon with GLP-1 ...

announced today its plan to conduct a clinical study on the combined use of the Allurion Balloon and GLP-1 agonists, aiming to improve long-term adherence and tolerability to GLP-1 therapy.

Although the Allurion Balloon is currently an investigational device in the United States, the company offers the Allurion Virtual Care Suite to healthcare providers separately to tailor weight-loss ...

The Vatican did not provide further details about the condition of the pope, who has been in the hospital for more than a week.

Pope Francis was conscious but still receiving high flows of supplemental oxygen Sunday following a respiratory crisis and ...

Winthrop Hot Air Balloon Roundup is a highly-anticipated event in Washington. Mark your calendar this February so you don't ...

RenovoRx (RNXT) highlighted its recent abstract presentation at the 2025 Society of Interventional Oncology Annual Conference in Las Vegas, ...

The Remount Foundation offers free mental health services, using horses to help military members combat PTSD, depression, and other challenges.